An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

Alzheimer's disease (AD) is the most common neurodegenerative disease. Imbalance between the production and clearance of amyloid β (Aβ) peptides is considered to be the primary mechanism of AD pathogenesis. This amyloid hypothesis is supported by the recent success of the human anti‐amyloid ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yu‐Sung, Chen, Zih‐ten, Liao, Tai‐Yan, Lin, Chen, Shen, Howard C‐H, Wang, Ya‐Han, Chang, Chi‐Wei, Liu, Ren‐Shyan, Chen, Rita P‐Y, Tu, Pang‐hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412883/
https://www.ncbi.nlm.nih.gov/pubmed/28356312
http://dx.doi.org/10.15252/emmm.201606666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412883/
https://www.ncbi.nlm.nih.gov/pubmed/28356312
http://dx.doi.org/10.15252/emmm.201606666

Ejemplares similares